Evidence map›Paper›PMID 37666282›Full record

ReviewProgress in lipid research2023

The skin barrier: An extraordinary interface with an exceptional lipid organization.

Joke A Bouwstra, Andreea Nădăban, Wim Bras, Clare McCabe, Annette Bunge, Gerrit S Gooris

Open access · hybridAbstract readReview
In one paragraph

Review in Progress in lipid research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
34.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 122 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Multi-omics uncovers the critical role of ceramide-mediatedJournal of pharmaceutical analysis · 2026
    Article
  4. Article
  5. Review
  6. Cells · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Joke A BouwstraDivision of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. Electronic address: bouwstra@chem.leidenuniv.nl.
Andreea NădăbanDivision of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Wim BrasChemical Sciences Division, Oak Ridge National Laboratory, One Bethel Valley Road, Oak Ridge, TN 37831, United States of America.
Clare McCabeSchool of Engineering & Physical Science, Heriot-Watt University, Edinburgh, Scotland, UK.
Annette BungeDepartment of Chemical and Biological Engineering, Colorado School of Mines, Golden, CO 80401, United States of America.
Gerrit S GoorisDivision of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Leiden University · NLCentre for Human Drug Research · NLColorado School of Mines · USHeriot-Watt University · GBOak Ridge National Laboratory · US

Funding

Insights into skin barrier function: In silico and experimental studies of healthy and diseased stratum corneum lipid modelsR01AR072679 · NIAMS · VANDERBILT UNIVERSITY · PI LAIBINIS, PAUL E · 2018 to 2022
$1.5M
NIAMS NIH HHS R01 AR072679
6 · The paper itself

Abstract

The barrier function of the skin is primarily located in the stratum corneum (SC), the outermost layer of the skin. The SC is composed of dead cells with highly organized lipid lamellae in the intercellular space. As the lipid matrix forms the only continuous pathway, the lipids play an important role in the permeation of compounds through the SC. The main lipid classes are ceramides (CERs), cholesterol (CHOL) and free fatty acids (FFAs). Analysis of the SC lipid matrix is of crucial importance in understanding the skin barrier function, not only in healthy skin, but also in inflammatory skin diseases with an impaired skin barrier. In this review we provide i) a historical overview of the steps undertaken to obtain information on the lipid composition and organization in SC of healthy skin and inflammatory skin diseases, ii) information on the role CERs, CHOL and FFAs play in the lipid phase behavior of very complex lipid model systems and how this knowledge can be used to understand the deviation in lipid phase behavior in inflammatory skin diseases, iii) knowledge on the role of both, CER subclasses and chain length distribution, on lipid organization and lipid membrane permeability in complex and simple model systems with synthetic CERs, CHOL and FFAs, iv) similarity in lipid phase behavior in SC of different species and complex model systems, and vi) future directions in modulating lipid composition that is expected to improve the skin barrier in inflammatory skin diseases.

Indexed as

SkinSkin DiseasesCeramidesEpidermisFatty Acids, NonesterifiedHumansCeramidesFatty Acids, NonesterifiedInflammatory skin diseasesPermeabilitySkin barrier functionStratum corneum lipid compositionStratum corneum lipids

Identifiers

PMID37666282
PMCPMC10841493
OpenAlexW4386409353

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.